A Breakthrough for the Invisible Affliction: FDA Approves First-Ever Treatment for Cholestatic Itch in Liver Disease
- April 10, 2026
EMERALD‑3 Trial Shows Benefit of Dual Immunotherapy–Based Strategy in Embolization‑Eligible Liver Cancer
Can We Fix This Broken Heart? – Part 4
Breaking Through Depression’s Barriers: Real-World Evidence Demonstrates Spravato’s Long-Term Effectiveness
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
A Breakthrough for the Invisible Affliction: FDA Approves First-Ever Treatment for Cholestatic Itch in Liver Disease bit.ly/3O9dgEH Read now at PatientWorthy.com
#PatientWorthy #cholestaticitch #PrimaryBiliaryCholangitis
National Public Health Week reminds us that the health of our communities starts with the choices we make today. From preventing chronic diseases to ensuring access to healthcare for all, every step we take matters. This week, let's celebrate the power of public health in creating healthier, safer, and more equitable communities. Together, we can build a stronger, healthier future. #NationalPublicHealthWeek #HealthEquity #PatientWorthy
HIV affects millions globally—but myths about who gets it and how it spreads persist. Here's what's real: HIV doesn't discriminate, certain communities face greater barriers, it spreads through specific routes only, and treatment works. Share your story with us here! bit.ly/4dV7gru #HIV #hivawareness #hiveducation #HIVFacts #GetTested #PatientWorthy
